China International Capital Corp

Chinese detergent maker Blue Moon Group has raised HK$9.8bn ($1.27bn) from its Hong Kong IPO, which saw a strong turnout from global and local investors.

Mainland-based Jacobio Pharmaceuticals has kicked off the roadshow for its Hong Kong listing. It is eyeing a valuation of up to HK$10.6bn ($1.37bn).

Chinese financial technology company Bairong is targeting Hong Kong for its IPO, having filed a draft prospectus with the city’s bourse.

Harbour Biomed has pocketed HK$1.71bn ($220.8m) by pricing its IPO just above the mid point of the marketed range.

Jinan Lixia Holding Group Co came to the dollar bond market at the end of last week, bagging $300m from a three year deal.

Vesync, a home appliance retailer, kicked off the roadshow for its up to HK$1.55bn ($200.1m) IPO in Hong Kong on Monday, with the company's growth story during the pandemic expected to appeal to investors.

Dada Nexus, which operates on-demand retail and delivery platforms in China, raised $450m this week after selling a chunk of new equity.

Blue Moon Group, a Chinese detergent maker, saw the book for its up to HK$9.8bn ($1.3bn) IPO covered within hours of opening on Friday.

Chinese property developer Longfor Group Holdings tapped equity investors for HK$4.7bn ($606.3m) through a top-up placement on Tuesday.

China Resources Mixc Lifestyle Services, the property management business of state-owned developer China Resources Land, is set to price its HK$12.3bn ($1.58bn) Hong Kong IPO at the top end of guidance.

Jacobio Pharmaceuticals is preparing to launch the roadshow for its Hong Kong IPO after winning approval to list from the city’ stock exchange last week.

China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing.